Advances in Magnetic Resonance Imaging: Applications in Body Imaging

References

• Stack J P, Antoun N M, Jenkins J PR, et al. Gadolinium-DTPA as a contrast agent in magnetic resonance imaging of the brain. Neuroradiology 1988; 30: 145–154
   PubMed Web of Science ®Google Scholar
• Takemoto K, Matsumura Y, Hashimoto H, et al. MR imaging of intraspinal tumors–Capability in histological differentiation and compartmentalization of extramedullary tumors. Neuroradiology 1988; 30: 303–309
   PubMed Web of Science ®Google Scholar
• Russell E J, Geremia G K, Johnson C E, et al. Multiple cerebral metastases: Detectability with Gd-DTPA-enhanced MR imaging. Radiology 1987; 165: 609–617
   PubMed Web of Science ®Google Scholar
• Westbroolk C, Kraut C. MRI in Practice. Blackwell Scientific Publications, Oxford 1993; 1–46
   Google Scholar
• Mitchell D G, Burk D L, Vinitski S, et al. The biophysical basis of tissue contrast in extracranial MR imaging. AJR 1987; 149: 831–837
   PubMed Web of Science ®Google Scholar
• Smith R C, Reinhold C, McCauiey T R, et al. Multicoil high-resolution fast spin-echo MR imaging of the female pelvis. Radiology 1992; 184: 671–675
   PubMed Web of Science ®Google Scholar
• McCauiey T R, McCarthy S, Lange R. Pelvic phased array coil: imaging quality assessment for spin-echo MR imaging. Magn Reson Imaging 1992; 10: 513–522
   PubMed Web of Science ®Google Scholar
• Kier R. Magnetic resonance imaging of the uterus. MRI Clin North Am 1994; 2: 189–210
   PubMedGoogle Scholar
• DiSaia P J, Creasman W T. Clinical Gynecologic Oncology4th ed. CV Mosby, St. Louis 1993; 58–125
   Google Scholar
• Hricak H, Powell C B, Yu K K, et al. Invasive cervical carcinoma. Role of MR imaging in pretreatment work-up cost minimization and diagnostic efficacy analysis. Radiology 1996; 198: 403–409
   PubMed Web of Science ®Google Scholar
• Mezrich R. Magnetic resonance imaging–Applications in uterine cervical cancer. MRI Clin North Am 1994; 2: 211–243
   PubMedGoogle Scholar
• Kim S H, Choi B I, Han J K, et al. Preoperative staging of uterine cervical carcinoma: Comparison of CT and MR in 99 patients. J Comput Assist Tomogr 1993; 17: 633–640
   PubMed Web of Science ®Google Scholar
• Hricak H, Lacey C G, Sandles L G, et al. Invasive cervical carcinoma: Comparison of MR imaging and surgical findings. Radiology 1988; 166: 623–631
   PubMed Web of Science ®Google Scholar
• Togashi K, Nishimura K, Sagon T, et al. Carcinoma of the cervix: Staging with MR imaging. Radiology 1989; 171: 245–251
   PubMed Web of Science ®Google Scholar
• Boronow R C, Morrow C P, Creasnan W T. Surgical staging in edometrial cancer; Clinical-pathological findings of a prospective study. Obstet Gynecol 1984; 63: 825–832
   PubMed Web of Science ®Google Scholar
• Posniak H V, Olson M C, Dudiak C, et al. MR imaging of uterine carcinoma: Correlation with clinical and pathologic findings. Radiographics 1990; 10: 15–27
   PubMed Web of Science ®Google Scholar
• Weinreb J C, Barkoff N D, Megibow A, et al. The value of MR imaging in distinguishing leiomyomas from other solid pelvic masses when sonography is indeterminate. AJR 1990; 154: 295–299
   PubMed Web of Science ®Google Scholar
• Outwater E K, Schlebler M. Magnetic resonance imaging of the ovary. MRI Clin North Am 1994; 2: 245–273
   PubMedGoogle Scholar
• Soyer P, Clement de Givry S, Gueye C, et al. Detection of focal hepatic lesions with MR imaging: prospective comparison of T2-weighted fast spin echo with and without fat suppression, T2-weighted breathhold fast spin-echo, and gadolinium chelate-enhanced 3D gradient recalled imaging. AJR 1996; 166: 1115–1121
   PubMed Web of Science ®Google Scholar
• Ros P R. Malignant Liver Tumors. Textbook of Gastrointestinal Radiology, R M Gore, M S Levine, I Laufer. WB Saunders, Philadelphia 1994; Vol. 2: 1897–1946
   Google Scholar
• Schnall M. Magnetic resonance imaging of focal liver lesions. Semin Roentgenol 1995; 30: 347–361
   PubMed Web of Science ®Google Scholar
• Winston S W, Herfkens R J, Jeffrey R B, et al. Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangioma from malignancies at 1.5 Tesla. Radiology 1993; 189: 863–870
   PubMed Web of Science ®Google Scholar
• Outwater E, Tomaszewski J E, Daly J M. Hepatic colorectal metastases: Correlation of MR imaging and pathologic appearance. Radiology 1991; 180: 327–322
   PubMed Web of Science ®Google Scholar
• Mitchell D G, Rubin R, Siegelman E S, et al. Hepatocellular carcinoma within siderotic regenerative nodules: Appearance as a nodule within a nodule on MR images. Radiology 1991; 178: 101–103
   PubMed Web of Science ®Google Scholar
• Mitchell D G. Focal manifestations of diffuse liver disease at MR imaging. Radiology 1992; 185: 1–11
   PubMed Web of Science ®Google Scholar
• Ros P R, Freeny P C, Harms S E, et al. Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy on the detection of focal hepatic lesions. Radiology 1995; 196: 481–488
   PubMed Web of Science ®Google Scholar
• Vogl T J, Hammerstingl R, Schwartz W. Superparamagnetic iron oxide-enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology 1996; 198: 881–887
   PubMed Web of Science ®Google Scholar
• Glazer H S, Weyman P J, Sagel S S, et al. Nonfunctioning adrenal masses: Incidental discovery on computed tomography. AJR 1982; 139: 81–85
   PubMed Web of Science ®Google Scholar
• Mitchell D G, Crovello M, Matteucci T, et al. Benign adrenocortical masses: Diagnosis with chemical shift MR imaging. Radiology 1992; 185: 345–351
   PubMed Web of Science ®Google Scholar
• Tsushima Y, Ishizaka H, Matsumoto M. Adrenal masses: Differentiation with chemical shift, fast low-angle shot MR Imaging. Radiology 1993; 186: 705–709
   PubMed Web of Science ®Google Scholar
• Schwartz L H, Panicek D M, Koutcher J A, et al. Adrenal masses in patients with malignancy: Prospective comparison of echo-planar, fast spin echo, and chemical-shift MR imaging. Radiology 1995; 197: 421–4125
   PubMed Web of Science ®Google Scholar
• Lee M J, Mayo-Smith W, Hahn P F, et al. State-of-the-art MR imaging of the adrenal gland. Radiographics 1994; 14: 1015–1027
   PubMed Web of Science ®Google Scholar
• Winston C B, Mitchell D G, Outwater E K, et al. Pancreatic signal intensity on T1-weighted fat saturation MR images: Clinical correlation. J Magn Reson Imaging 1995; 5: 267–271
   PubMed Web of Science ®Google Scholar
• Semelka R C, Asher S M. MR imaging of the pancreas. Radiology 1993; 188: 593–602
   PubMed Web of Science ®Google Scholar
• Gabata T, Matsui O, Kadoya M, et al. Small pancreatic adenocar-Winston and Schwartz cinomas: Efficacy of MR imaging with fat suppression and gadolinium enhancement. Radiology 1994; 193: 683–688
   PubMed Web of Science ®Google Scholar
• Muller M G, Meyenberger C, Bertschinger P, et al. Pancreatic tumors: Evaluation with endoscopic US, CT, and MR imaging. Radiology 1994; 190: 745–751
   PubMed Web of Science ®Google Scholar
• Megibow A J, Zhou X H, Rotterdam, et al. Pancreatic adenocarcinoma: CT versus MR inaging in the evaluation of resectability: Report of the Radiology Diagnostic Oncology Group. Radiology 1995; 195: 327–332
   PubMed Web of Science ®Google Scholar
• Mitchell D G, Cruvella M, Eschleman D J, et al. MRI of pancreatic gastrinomas. J Comput Assist Tomogr 1992; 16: 583–585
   PubMed Web of Science ®Google Scholar
• Panicek D M, Gatsonis C, Rosenthal D I, et al. CT and MR imaging in the local staging of primary malignant musculoskeletal neoplasms: Report of the Radiology Diagnostic Oncology Group. Radiology 1997; 202: 237–246
   PubMed Web of Science ®Google Scholar
• Jelinek J S, Kransdorf M J, Utz J A, et al. Imaging of pigmented villonodular synovitis with emphasis on MR imaging. AJR 1989; 152: 337–342
   PubMed Web of Science ®Google Scholar